Pariplay continues North America expansion with green light to go live in Ontario

 

Aspire Global’s Pariplay Ltd, the leading aggregator and content provider, has taken another major step in its North America expansion with the awarding of its Ontario licence.

The Gaming-Related Supplier License will see Pariplay’s premium aggregation offering available throughout the Canadian province, with the provider already announcing its intention to go live with a number of major operators and partners in the province as soon as the market opens on April 4, 2022.

It marks the continuation of Pariplay’s impressive growth in North America, having recently gone commercially live in Alberta, as well as being awarded its West Virginia and Michigan licences after making its US debut in New Jersey over a year ago.

Pariplay’s Fusion™ product is the most flexible aggregation platform in the market and features leading titles and localised content from 80+ vendors, as well as high-performing engagement tools.

Adrian Bailey, Managing Director at Pariplay, said: “We are very pleased to be granted our Ontario licence, which allows us to build on our success and bringing relevant and varied content to regulated markets.

“We’ve made a concerted effort to grow our reach in Canada both through signing new partners and gaining new licences, and this approach continues to generate success for us. It is an exciting time at Pariplay and we can’t wait to get started in Ontario.”

Previous articleFitzdares Secures AGCO Registration for Ontario Market
Next articleRobert Smith Joins The Sports Leadership Show!
George Miller has started working in the gaming industry as an Editor/Content Manager in 2016 and since then he has acquired many experiences when it comes to interviews and newsworthy subject covering. In 2017, he became Head of Content and he is responsible for the editorial team, press release and story covering on multiple websites that are part of Hipther Agency, including EuropeanGaming.eu.

LEAVE A REPLY

Please enter your comment!
Please enter your name here